Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This facility-based, multi-center randomized controlled trial (RCT) will test the non-inferiority of short-term (7 day) urethral catheterization compared to longer-term (14 day) urethral catheterization in terms of predicting fistula repair breakdown three months following urinary fistula repair surgery. The study will be conducted among 507 women with simple fistula presenting at 8 study sites in Sub-Saharan Africa for fistula repair surgery.
| Condition | Intervention |
|---|---|
|
Vaginal Fistula |
Procedure: 7-day catheterization following fistula repair surgery Procedure: 14 day catheterization |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery |
- Fistula repair breakdown three months following fistula repair surgery as assessed by a urinary dye test. [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
- Repair breakdown one week following catheter removal [ Time Frame: 14 days or 21 days post-repair ] [ Designated as safety issue: Yes ]
- Intermittent catheterization due to urinary retention [ Time Frame: 7 or 14 days post repair ] [ Designated as safety issue: Yes ]
- Prolonged hospitalization [ Time Frame: 14 or 21 days post-repair ] [ Designated as safety issue: No ]
- Catheter blockage [ Time Frame: 14 or 21 days post repair ] [ Designated as safety issue: Yes ]
- Self-reported residual incontinence [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]
- The occurrence of septic or febrile episodes [ Time Frame: 14 or 21 days post-repair ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 507 |
| Study Start Date: | January 2012 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: 7-day catheterization |
Procedure: 7-day catheterization following fistula repair surgery
This group will have an indwelling urethral catheter for 7 days following fistula repair surgery.
|
| Active Comparator: 14-day catheterization |
Procedure: 14 day catheterization
This group will have an indwelling urethral catheter for 14 days following fistula repair surgery.
|
Detailed Description:
A vaginal fistula is a devastating condition, affecting an estimated 2 million girls and women across Africa and Asia. Finding ways of providing services in a more efficient and cost-effective manner, without compromising surgical outcomes and the overall health of the patient, is paramount. Shortening the duration of urethral catheterization following fistula repair surgery would increase treatment capacity (by freeing available bed space and increasing availability of nursing staff), lower costs of services, and potentially lower risk of healthcare-associated infections among fistula patients. There is a lack of empirical evidence supporting any particular length of time for urethral catheterization following fistula repair surgery.
This facility-based, multi-center randomized controlled trial (RCT) will test the non-inferiority of short-term (7 day) urethral catheterization compared to longer-term (14 day) urethral catheterization in terms of predicting fistula repair breakdown. The primary outcome is fistula repair breakdown three months following fistula repair surgery as assessed by a urinary dye test, a routine practice in fistula repair services. t. Secondary outcomes will include repair breakdown one week following catheter removal, intermittent catheterization due to urinary retention and the occurrence of septic or febrile episodes, prolonged hospitalization (defined as a stay at the facility beyond one week following initial catheter removal related to an adverse event), catheter blockage, and self-reported residual incontinence. This study will be conducted among 507 women with simple fistula presenting at 8 study sites for fistula repair surgery over the course of 16-18 months at each site.
Eligibility| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Have a "simple" fistula, as determined at the end of fistula repair surgery (irrespective of the number of prior repair attempts and the cause of the fistula, with the exceptions noted under the exclusion criteria below)
- Have a closed fistula at completion of surgery
- Have a closed fistula 7 days after surgery (i.e. at the time of randomization)
- Understand study procedures and requirements
- Agree to return to the facility for one follow-up visit three month after the date of surgery
- Provide informed consent to participate in the study or in the case of non-emancipated minors, both consent to the study and receive proxy consent to participate in the study
- Have no contraindications precluding their participation.
Exclusion Criteria:
- Have a fistula that is determined to be "not simple" (i.e. intermediate or complex)
- Have a fistula that is radiation-induced, associated with cancer or due to lymphogranuloma venereum (These cases will be excluded because the healing process is very different from fistula resulting from other causes. We expect there to be few cases of these fistulas at the study sites)
- Have a fistula that is not closed immediately after surgery or 7 days after surgery (i.e. at the time of randomization)
Contacts and Locations| Contact: Mark A Barone, DVM, MS | (212) 561-8084 | mbarone@engenderhealth.org |
| Contact: Mariana Widmer | +41 22 791 43 23 | widmerm@who.int |
| Congo, The Democratic Republic of the | |
| Hôpital Saint Joseph | Recruiting |
| Kinshasa, Congo, The Democratic Republic of the | |
| Ethiopia | |
| Gondar University Hospital | Recruiting |
| Gondar, Ethiopia | |
| Guinea | |
| L'Hôpital Préfectoral de Kissidougou | Recruiting |
| Kissidougou, Guinea | |
| Kenya | |
| Kenyatta National Hospital | Recruiting |
| Nairobi, Kenya | |
| Nigeria | |
| National Obstetric Fistula Centre | Recruiting |
| Abakaliki, Nigeria | |
| Niger | |
| Maternité Centrale de Zinder | Recruiting |
| Zinder, Niger | |
| Sierra Leone | |
| Aberdeen Women's Centre | Recruiting |
| Freetown, Sierra Leone | |
| Uganda | |
| Kagando Hospital | Recruiting |
| Kasese District, Uganda | |
| Principal Investigator: | Mark A Barone, DVM, MS | EngenderHealth |
| Study Director: | Mariana Widmer | World Health Organization |
More Information
No publications provided by EngenderHealth
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | EngenderHealth |
| ClinicalTrials.gov Identifier: | NCT01428830 History of Changes |
| Other Study ID Numbers: | A65783 |
| Study First Received: | September 2, 2011 |
| Last Updated: | February 6, 2013 |
| Health Authority: | United Nations: World Health Organization |
Keywords provided by EngenderHealth:
|
fistula catheter surgery |
obstetrics gynecology urology |
Additional relevant MeSH terms:
|
Fistula Vaginal Fistula Pathological Conditions, Anatomical Vaginal Diseases Genital Diseases, Female |
ClinicalTrials.gov processed this record on May 19, 2013